Platelet-Rich Plasma for Peyronie's Disease
ConditionPeyronies Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorHerlev Hospital
About this trial
The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.
Eligibility criteria
Qualifiers
18 years or older
Be able to provide written informed consent
Diagnosis of PD without active pain and without progressive curvature over the past 3 months (fibrotic phase).
Penile curvature of 30-95 degrees
Disqualifiers
Erectile Dysfunction unresponsive to on-demand PDE5 inhibitors
Hourglass malformation
Severely calcified plaques where injection is considered unfeasible
Intrapenile plaque
Trial design
Treatments tested in this trial
- Autologous Platelet Rich Plasma
- Saline solution
Treatment groups
84 Participants
are divided into 2 treatment groupsSponsors and collaborators
Herlev Hospital
Lead sponsor
Herlev and Gentofte Hospital
Sponsor institution
Source ClinicalTrials.gov